ClinicalTrials.Veeva

Menu

Effect of a Topical Ketamine on Acute and Chronic Pain, Dose Finding

A

Assiut University

Status and phase

Completed
Phase 3
Phase 2

Conditions

Breast Cancer

Treatments

Drug: group (B)
Drug: group (A)
Drug: group (c)

Study type

Interventional

Funder types

Other

Identifiers

NCT03165149
17100205

Details and patient eligibility

About

The aim of this study is to investigate the effect of addition of different doses of Ketamine locally in acute and chronic post-mastectomy pain after breast cancer surgery and on the probability of developing chronic post-mastectomy pain.

Enrollment

90 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American society of heart association class I-II female patients
  • aged 18-60 years
  • scheduled for modified radical mastectomy with axillary dissection for breast carcinoma

Exclusion criteria

  • known allergy to the study drugs
  • significant cardiac-
  • respiratory-
  • renal or hepatic disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

90 participants in 3 patient groups

Group (A)
Active Comparator group
Description:
patients will receive 1mg / kg of Ketamine diluted by 20 ml saline (0.9 % )
Treatment:
Drug: group (A)
Group (B)
Active Comparator group
Description:
patients will receive 2 mg /kg of Ketamine diluted by 20 ml saline (0.9 %) a
Treatment:
Drug: group (B)
Group (C)
Active Comparator group
Description:
patients will receive 3 mg / kg of Ketamine diluted by 20 ml saline (0.9 %)
Treatment:
Drug: group (c)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems